Mohammad Morad Farajollahi, Sepideh Hamzehlou, Ahmad Mehdipour, Ali Samadikuchaksaraei*
|
Asghar Mesbahi*, Farideh Jamali, Nahideh garehaghaji
|
|
|
Sahar Rehman, Kanwal Rehman, Muhammad Sajid Hamid Akash*
|
Jaleh Barar  , Yadollah Omidi*
|
Mohammad Babaei, Maryam Ganjalikhani*
|
Jaleh Barar , Yadollah Omidi*
|
Jaleh Barar* , Yadollah Omidi*
|
|
|
Yadollah Omidi , Jaleh Barar*
|
Jaleh Barar* , Yadollah Omidi*
|
Mohammad A. Rafi, Yadollah Omidi*
|
Mohammad Amir Amirkhani, Rashin Mohseni, Masoud Soleimani, Alireza Shoae-Hassani, Mohammad Ali Nilforoushzadeh*
|
Marzieh Fathi, Jaleh Barar , Ayuob Aghanejad, Yadollah Omidi*
|
|
|
Mohammad Amir Amirkhani, Alireza Shoae-Hassani, Masoud Soleimani, Somayeh Hejazi, Leila Ghalichi, Mohammad Ali Nilforoushzadeh*
|
Amir Mehdizadeh, Morteza Bonyadi, Masoud Darabi, Reza Rahbarghazi, Soheila Montazersaheb, Kobra Velaei, Maghsood Shaaker, Mohammad-Hossein Somi*
|
Farnaz Fahimi, Mohammad Reza Tohidkia, Mehdi Fouladi, Reza Aghabeygi, Naser Samadi, Yadollah Omidi*
|
Yadollah Omidi*
|
|
|
Yadollah Omidi*
|
Jaleh Barar*
|
Jaleh Barar , Yadollah Omidi*
|
Jaleh Barar , Ayuob Aghanejad, Marziyeh Fathi, Yadollah Omidi*
|
Marziyeh Fathi, Jaleh Barar*
|
Abbas Asoudeh-Fard, Abolfazl Barzegari, Alireza Dehnad, Sepideh Bastani, Asal Golchin, Yadollah Omidi*
|
Masumeh Zamanlu, Morteza Eskandani*, Reza Mohammadian, Nazila Entekhabi, Mohammad Rafi, Mehdi Farhoudi*
|
Marziyeh Fathi, Parham Sahandi Zangabad, Sima Majidi, Jaleh Barar, Hamid Erfan-Niya, Yadollah Omidi*
|
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar , Yadollah Omidi*
Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.
|
Nastran Hashemzadeh, Khosro Adibkia , Jaleh Barar*
|
Mostafa Akbarzadeh Khiavi , Azam Safary , Mohammad Hossein Somi*
Colorectal cancer (CRC) as a malignancy shows high mortality rate worldwide because of metastasis and drug resistance. Targeted multimodal nanosystems (NSs) can be developed and used against CRC with much better clinical outcomes.
|
Stephan Born*, Max Johannes Dörfel, Philip Hartjen, Seyed Ali Haschemi Yekani, Julia Luecke, Juliane Katharina Meutsch, Julie Katharina Westphal, Moritz Birkelbach, Robert Köhnke, Ralf Smeets, Michael Krueger
The purification process for stromal vascular fraction (SVF) can be performed using additional short plastic adherence incubation step (16-20h). This process leads in 24h to a predictable GMP-compliant cell-product. This product is more homogenous than the SVF.
|
Mitra Dolatkhah, Yadollah Omidi*
Dr. Yadollah Omidi (Pharm.D., Ph.D.) is a Professor of Pharmaceutical Sciences at TUOMS Faculty of Pharmacy, working on advanced multifunctional nanobiosystems. He has worked at Cardiff University and University of Pennsylvania. He has published over 210 papers and 18 book chapters, supervised and mentored over 100 graduate/postgraduate students/researchers.
|
Mohammad A. Rafi , Paola Luzi, David A. Wenger*
Krabbe disease (KD) is an autosomal recessive lysosomal disorder that imposes defective myelination in the peripheral and central nervous systems. Twitcher combining bone marrow transplantation with AAVrh10-mGALC can have a great extension of life in the murine model of KD.
|
Nadezhda V. Maksimova , Anna V. Michenko, Olga A. Krasilnikova , Ilya D. Klabukov* , Igor Yu. Gadaev , Michael E. Krasheninnikov , Pavel A. Belkov, Aleksey V. Lyundup
Three-year follow-up of patients, treated for diabetic foot ulcers with mesenchymal stromal cells that revealed absence of ulcer recurrence, neoplasms, and scar contracture. Collagen ultrasound density decreased by 57% and the epidermal thickness increased by 72% in the area of healed ulcers.
|
Siamak Alizadeh , Abolghasem Esmaeili, Jaleh Barar , Yadollah Omidi*
Optogenetics approaches can provide us with outstanding tool to extend our understanding of how cells perceive, respond, and behave in meeting with complex signals, particularly in terms of cancer evasion from the anticancer immune system functions.
|
Efthymia-Iliana Matthaiou , Yi Guo, Jaleh Barar , Raphael Sandaltzopoulos, Lana E. Kandalaft, Chunsheng Li*, George Coukos, Yadollah Omidi*
Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) functionalized with polyethylene glycol (PEG)and anti-TEM1 antibody fragment (78Fc) and loaded with necrosis-inducing agent shikonin (SHK)(78Fc-PLGA-SHK NPs) is a highly effective immunostimulating nanomedicine against theTEM1-expressing cells for targeted therapy of solid tumors.
|
Raghdah S. Bawadud , Mayson H. Alkhatib*
Co-delivery of NE-DTX+TQ may probably inhibit the proliferation of T47D via the induction of apoptosis and autophagy pathways and impede the migration by reducing the BCSC population and downregulating TWIST-1 expression to decrease the epithelial-to-mesenchymal transition (EMT) of breast cancer cells
|
Mohammad A Rafi* , Paola Luzi, David A Wenger
Our results demonstrate that, it may be possible to treat human KD patients with high dose AAVrh10 without blood stem cell transplantation which would eliminate the side effects of HSCT.
|
Behnaz Babaye Abdollahi , Marjan Ghorbani, Hamed Hamishehkar, Reza Malekzadeh, Alireza Farajollahi*
This study shows the positive effect of synthesized Trastuzumab loaded PEG-Fe3O4@Au nanoparticleson increasing the death rate of Breast cancer cells during megavoltage radiation therapy.
|
Sevda Jafari , Saba Heydarian, Raymond Lai, Elnaz Mehdizadeh Aghdam, Ommoleila Molavi*
Evaluation of different variables on preparation of Microspheres. F9; Freeze-dried particles prepared by W/O/W emulsion method, F1; Dried particles on the tray at room temperature, F16; Freeze-dried particles prepared by S/O/O emulsion method. W/O/W; Water in oil in water, S/O/O; Solid in oil in oil.
|
Maryam Sayahinouri , Sahar Mashayekhi Firouz , Amin Ebrahimi Sadrabadi , Mina Masoudnia , Mahnaz Abdolahi , Fatemeh Jafarzadeh , Meshkat Nouripour , Sana Mirzazadeh , Nazanin Zangeneh , Arsalan Jalili* , Nasser Aghdami
In COVID-19 infection, the various functions of immune cells lead to defense or failure against the virus. Cell therapy is of great importance as a new treatment for COVID-19 infection. Therefore, in this review, we have dealt with the function of immune cells against the SARS-Cov-2 virus and new treatment methods for this disease with the help of different cell types
|
Leila Rostamizadeh , Ommoleila Molavi* , Mohsen Rashid, Fatemeh Ramazani, Behzad Baradaran, Afsaneh Lavasanaifar, Raymond Lai
In this paper, we will review the application of the four most widely studied TLR agonists including agonists of TLR3, 4, 7, and 9 in cancer immunotherapy.
|
Mohammad A. Rafi*
Cutting viral dose in half or using BM cells from heterozygote mice in a combination of BMT and gene therapy treatments result in a similar reduction in lifespan of the treated mice.
|
Xiuying Li* , Xianqin Luo, Shunqin Hu
Our results indicated that losartan can modulate the tumor microenvironment, and improve the efficacy of anti-PD-L1 mAb.
|
Mina Yousefnezhad, Soodabeh Davaran* , Mirzaagha Babazadeh, Abolfazl Akbarzadeh, Hamidreza Pazoki-Toroudi
Drug repurposing is an effective strategy for identifying and using approved drugs for new therapeutic purposes. We investigated co-delivery of the antitumor drugs, doxorubicin (DOX), and ezetimibe (EZ) as a cholesterol uptake-blocking drug with PCEC on prostate cancer cell line (PC3).
|
Yalda Rahbar Saadat , Jaleh Barar*
Jaleh Barar (PharmD, Ph.D.) is a Full Professor at the Faculty of Pharmacy, Tabriz University of Medical Sciences. Professor Barar is working on various aspects of pharmaceutical cell biology with particular emphasis on the development of novel drug delivery/targeting systems. Dr Barar is listed among top 1% of world scientists based on ESI ranking system.
|
Zeinab Ghazvinian , Shahrokh Abdolahi, Mohammad Ahmadvand, Amir Hossein Emami, Samad Muhammadnejad, Hamid Asadzadeh Aghdaei, Jafar Ai, Mohammad Reza Zali, Iman Seyhoun, Javad Verdi* , Kaveh Baghaei*
|
Nahid Moradi , Mina Soufi-Zomorrod* , Simzar Hosseinzadeh, Masoud Soleimani
|
Katelyn R. Einloth , Scott Gayfield, Thomas McMaster, Alexander Didier, Lance Dworkin, Justin Fortune Creeden*
|
Seyed Mostafa Monzavi , Amir Ali Hamidieh , Mohammad Vasei, Jafar Ai, Naser Ahmadbeigi, Hamid Arshadi, Samad Muhammadnejad* , Abdol-Mohammad Kajbafzadeh*
|
Mostafa Akbarzadeh-Khiavi , Azam Safary , Yadollah Omidi*
|
Farzaneh Bilan , Mohammad Amini, Mohammad Amin Doustvandi, Maryam Tohidast, Amir Baghbanzadeh, Seyed Samad Hosseini , Ahad Mokhtarzadeh* , Behzad Baradaran*
|
Hamed Zare , Hamid Bakherad* , Arman Nasr Esfahani, Mohamad Norouzi, Hossein Aghamollaei, Seyed Latif Mousavi Gargari, Fatemeh Mahmoodi, Mahdi Aliomrani, Walead Ebrahimizadeh
|
Farkhonde Hasannejad , Leila Montazeri, João F Mano* , Shahin Bonakdar* , Ahmad Fazilat
|
Maryam Samareh Salavatipour , Zahra Poursalehi, Negin Hosseini Rouzbahani, Sohaib Mohammadyar, Mohammad Vasei*
|
Azin Shahmohammadi , Hadi Samadian, Saeed Heidari Keshel, Khodabakhsh Rashidi, Amir Kiani, Masoud Soleimani*, Farjam Goudarzi*
|
Haryati Ahmad Hairi , Nurul Izzah Ibrahim, Muhammad Zulfiqah Sadikan, Putri Ayu Jayusman, Ahmad Nazrun Shuid*
|
Mohsen Rashid , Mina Ramezani, Ommoleila Molavi, Zeinab Ghesmati, Behzad Baradaran, Mehdi Sabzichi, Fatemeh Ramezani*
|
Sutude Fazilat , Fateme Tahmasbi, Mohammad Reza Mirzaei, Sarvin Sanaie, Zahra Yousefi, Solmaz Asnaashari, Shadi Yaqoubi, Ahad Banagozar Mohammadi* , Mostafa Araj-khodaei*
|
Devika Tripathi* , Prashant Pandey, Sakshi Sharma, Awani K Rai, Manjunatha Prabhu B.H.
|
Rakhshinda Habib* , Rabia Farhat, Mohsin Wahid, Jahanara Ainuddin
|
Aidin Shahrezaei , Maryam Sohani , Farinaz Nasirinezhad*
|
Mojtaba Ghobadi , Mohammad Foad Heidari, Arezoo Farhadi, Ali Shakerimoghaddam, Mahdi Ghorbani, Zahra Hami, Naeim Ehtesham, Javad Behroozi*
|